HRTX
Heron Therapeutics Inc
Price:  
3.42 
USD
Volume:  
1,593,794.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HRTX WACC - Weighted Average Cost of Capital

The WACC of Heron Therapeutics Inc (HRTX) is 7.9%.

The Cost of Equity of Heron Therapeutics Inc (HRTX) is 8.80%.
The Cost of Debt of Heron Therapeutics Inc (HRTX) is 6.15%.

Range Selected
Cost of equity 7.10% - 10.50% 8.80%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.30% - 7.00% 6.15%
WACC 6.4% - 9.4% 7.9%
WACC

HRTX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.71 1.01
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.10% 10.50%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.28 0.28
Cost of debt 5.30% 7.00%
After-tax WACC 6.4% 9.4%
Selected WACC 7.9%